关注
Zhenming Jin
Zhenming Jin
在 hnu.edu.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Z Jin, X Du, Y Xu, Y Deng, M Liu, Y Zhao, B Zhang, X Li, L Zhang, C Peng, ...
Nature 582 (7811), 289-293, 2020
40762020
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
W Dai, B Zhang, XM Jiang, H Su, J Li, Y Zhao, X Xie, Z Jin, J Peng, F Liu, ...
Science 368 (6497), 1331-1335, 2020
14162020
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
Z Jin, Y Zhao, Y Sun, B Zhang, H Wang, Y Wu, Y Zhu, C Zhu, T Hu, X Du, ...
Nature structural & molecular biology 27 (6), 529-532, 2020
4022020
Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
K Amporndanai, X Meng, W Shang, Z Jin, M Rogers, Y Zhao, Z Rao, ...
Nature communications 12 (1), 3061, 2021
1692021
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
Y Zhao, X Du, Y Duan, X Pan, Y Sun, T You, L Han, Z Jin, W Shang, J Yu, ...
Protein & cell 12 (11), 877-888, 2021
1092021
Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2
Y Zhao, Y Zhu, X Liu, Z Jin, Y Duan, Q Zhang, C Wu, L Feng, X Du, J Zhao, ...
Proceedings of the National Academy of Sciences 119 (16), e2117142119, 2022
942022
The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2
Z Jin, H Wang, Y Duan, H Yang
Biochemical and Biophysical Research Communications 538, 63-71, 2021
382021
OsMADS32 interacts with PI‐like proteins and regulates rice flower development
H Wang, L Zhang, Q Cai, Y Hu, Z Jin, X Zhao, W Fan, Q Huang, Z Luo, ...
Journal of Integrative Plant Biology 57 (5), 504-513, 2015
382015
High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
Y Zang, M Su, Q Wang, X Cheng, W Zhang, Y Zhao, T Chen, Y Jiang, ...
Protein & Cell 14 (1), 17-27, 2023
142023
Structure of Mpro 1 from COVID-19 virus and discovery of its inhibitors
J Zhenming, D Xiaoyu, X Yechun, D Yongqiang, L Meiqin, Z Yao, Z Bing, ...
bioRxiv, 2020
72020
Characterisation and gene mapping of a brittle culm mutant bc-s1 in rice
Z Jin, B Ping, H Shen, H Du, R Li, L Zhu, D Zhang, Z Yuan
Chinese Bulletin of Botany 51 (2), 167, 2016
42016
Using the inner membrane of Escherichia coli as a scaffold to anchor enzymes for metabolic flux enhancement
Y Wang, Y Wang, Y Wu, Y Suo, H Guo, Y Yu, R Yin, R Xi, J Wu, N Hua, ...
Engineering in Life Sciences 23 (2), e2200034, 2023
12023
Compound for treating and/or preventing diseases caused by coronavirus and use thereof
H Yang, JIN Zhenming, DU Xiaoyu, D Yinkai, Y Zhao, Y Xiuna, Z Rao
US Patent App. 17/924,802, 2023
2023
Application of disulfiram in coronavirus resistance
H Yang, JIN Zhenming, Y Xiuna, Y Zhao, Z Rao
US Patent App. 17/801,689, 2023
2023
Pharmaceutical use of ketoamide-based compound
H Liu, J Li, J Peng, XIE Xiong, W Dai, HU Shulei, C Li, L Zhang, ...
US Patent App. 17/796,076, 2023
2023
Pharmaceutical use of aldehyde-based compound
H Liu, J Li, W Dai, J Peng, XIE Xiong, HU Shulei, C Li, XU Yechun, ...
US Patent App. 17/759,807, 2023
2023
Use of an N-substituted pyridyl benzisoselazolone compound
H Yang, JIN Zhenming, Y Xiuna, Y Zhao, Z Rao
US Patent 11,464,765, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–17